James E. Francese - 07 Mar 2023 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Reporting relationship: Sr. VP, Comm. Ops., NA, APAC
Issuer ticker: STAA
Reported as of: 07 Mar 2023
Net transaction value: +$23,891
SEC form: 4
Accepted by SEC: 08 Mar 2023, 19:15:07 UTC
Prior SEC filing: 04 Jan 2023
Next SEC filing: 10 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Samuel Gesten as attorney-in-fact for James Francese

Key filing fact

James E. Francese filed Form 4 for STAAR SURGICAL CO (STAA) on 08 Mar 2023.

Key facts

This page summarizes James E. Francese's Form 4 filing for STAAR SURGICAL CO (STAA).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 08 Mar 2023, 19:15.

Change

Previous filing in this sequence was filed on 04 Jan 2023.
Current net transaction value: +$23,891.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STAA transaction

Common Stock

Tax liability

Transaction value: $39,063
Shares: -672
Change %: -1.9%
Price: $58.13
Shares after: 34,236
Date: 07 Mar 2023
Ownership: Direct

STAA transaction

Common Stock

Options Exercise

Transaction value: $62,955
Shares: +1,083
Change %: +3.2%
Price: $58.13
Shares after: 35,319
Date: 07 Mar 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Performance Stock Units (PSUs) converted into common shares on a one-to-one basis, with the amount representing the vesting of PSUs awarded on March 7, 2022, with achievement based on the Corporation's satisfaction of pre-established financial metrics.